§ Federal grant opportunity · PAR-28-017
National Biomedical Research Centers (P50 Clinical Trial Optional)
National Institutes of Health is accepting applications for National Biomedical Research Centers (P50 Clinical Trial Optional). The deadline is Rolling / not published and the published award range is $8.0M – $11.4M.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- Rolling / not published
- Award range
- $8.0M – $11.4M
- Eligibility
- other native american tribal organizations, special district governments, federally recognized native american tribal governments, state governments, other, city or township governments, for profit organizations other than small businesses, nonprofits non higher education with 501c3, private institutions of higher education, county governments, independent school districts, public and indian housing authorities, public and state institutions of higher education, nonprofits non higher education without 501c3, small businesses
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-28-017
Program overview
The National Biomedical Research Centers (NBRCs) are expected to provide scientific expertise, advanced equipment, infrastructure, and a range of well-characterized research models to researchers across the nation. Research at the NBRCs is supported by almost all NIH Institutes, as well as other federal agencies, including those that safeguard US national security interests. This NOFO emphasizes development of innovative human-based models and new technologies to reduce reliance on live research models. Applications must describe clear, actionable plans to reduce, refine, and replace whole-animal use by developing complementary and alternative approaches tailored to relevant use cases in biomedical research. Scientifically, the NBRCs function as centers of innovation in fundamental science as well as translational hubs that develop, refine, and test novel interventions for ultimate use in human patients. It is NIH’s intention that the NBRCs become leaders in the development and use of human-based approaches, including sophisticated in vitro and in silico models, known as New Approach Methodologies (NAMs). Clinical trials are allowed only as human-based NAMs, where applicable. This notice of funding opportunity (NOFO) is an open competition to increase opportunities for innovation, including NAMs research, at research centers with existing nonhuman primate colonies, and to further leverage existing capabilities in basic and translational research.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before Rolling / not published, allowing time for registration and validation.
Related grant opportunities
- Controlling and Preventing STIs in US Health Departments (CAP-STIs)
- Communications, Circuits, and Sensing-Systems
- NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous System
- Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional)
- Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Environmental Determinants of Diabetes in The Young Study (TEDDY) Data Coordinating Center (U01 Clinical Trial Not Allowed)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.